Fundraising FoxWellesley Pharmaceuticals
Newtown, US · Founded 2011 · 1 known investors
Find your way into Wellesley Pharmaceuticals
Sign up to find every way you can get introduced to Wellesley Pharmaceuticals
- Your email: who you already know at Wellesley Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Wellesley Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Nocturol, Inc. (Wellesley Pharma) is developing a treatment for nocturia, a medical condition in which people are woken frequently at night by the need to urinate. The company targets the hundreds of millions of people who experience multiple nighttime bathroom visits.
Founders & leadership
DA
David Alan DillChief Executive Officer and President
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.7M disclosed across 2 rounds · 2014–2015
▶$3.8MraisedOct 2017 · 14 investors · PharmaceuticalsRule 506(b)
▶$3.8MraisedOct 2017 · 14 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher LineberryDirector
- Candan KarabagliDirector
- Omer KarahanDirector
- David Alan DillExecutive Officer, Director
- Offering amount
- $5.8M
- Amount sold
- $3.8M
- Sales commissions
- $150K
- Placement agents
- Healthcare Capital and Mergers
- First sale
- Mar 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$934.9KraisedFeb 2015 · 18 investors · PharmaceuticalsRule 506(b)
▶$934.9KraisedFeb 2015 · 18 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David Alan DillExecutive Officer, Director
- Offering amount
- $3.4M
- Amount sold
- $934.9K
- Minimum investment
- $25K
- First sale
- Jul 2014
- Incorporated
- Limited Liability Company, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Wellesley Pharmaceuticals do?
- Nocturol, Inc. (Wellesley Pharma) is developing a treatment for nocturia, a medical condition in which people are woken frequently at night by the need to urinate. The company targets the hundreds of millions of people who experience multiple nighttime bathroom visits.
- Who are Wellesley Pharmaceuticals's investors?
- Wellesley Pharmaceuticals's investors include Keiretsu Forum.
- How much funding has Wellesley Pharmaceuticals raised?
- Wellesley Pharmaceuticals has disclosed $4.7M raised across 2 rounds.
- Where is Wellesley Pharmaceuticals headquartered?
- Wellesley Pharmaceuticals is headquartered in Newtown, US.